1)Yoshida K, Yamaguchi K, Okumura N, et al:Is conversion therapy possible in stage IV gastric cancer:the proposal of new biological categories of classification. Gastric Cancer 19:329-338, 2016
2)Yoshikawa T, Sasako M, Yamamoto S, et al:Phase Ⅱ study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg 96:1015-1022, 2009
3)Tsuburaya A, Mizusawa J, Tanaka Y, et al:Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101:653-660, 2014
4)Ito S, Sano T, Mizusawa J, et al:A phase Ⅱ study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis:JCOG1002. Gastric Cancer 20:322-331, 2017
5)Yoshikawa T, Kurokawa Y, Kitabayashi R, et al:A phase Ⅱ study of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 followed by gastrectomy with D2 plus para-aortic nodal dissection for gastric cancer with extensive lymph node metastasis:JCOG1704. J Clin Oncol 41(Suppl):354, 2023
6)Inoue K, Nakane Y, Kogire M, et al:Phase Ⅱ trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer. Eur J Surg Oncol 38:143-149, 2012
7)Yoshida M, Ohtsu A, Boku N, et al:Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group(JCOG)study. Jpn J Clin Oncol 34:654-659, 2004
8)Park IH, Kim SY, Kim YW, et al:Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement. Cancer Chemother Pharmacol 67:127-136, 2011
9)Yoshida K, Yasufuku I, Terashima M, et al:International Retrospective Cohort Study of Conversion Therapy for Stage Ⅳ Gastric Cancer 1(CONVO-GC-1). Ann Gastroenterol Surg 6:227-240, 2022
10)Morita S, Fukagawa T, Fujiwara H, et al:Questionnaire survey regarding the current status of super-extended lymph node dissection in Japan. World J Gastrointest Oncol 8:707-714, 2016
11)Katayama H, Tsuburaya A, Mizusawa J, et al:An integrated analysis of two phase Ⅱ trials(JCOG0001 and JCOG0405)of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis. Gastric Cancer 22:1301-1307, 2019
12)Takahari D, Ito S, Mizusawa J, et al:Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis(JCOG1002). Gastric Cancer 23:293-299, 2020
13)Wada T, Yoshikawa T, Sekine S, et al:Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy. Eur J Surg Oncol 48:333-338, 2022